Literature DB >> 7517606

Granulocyte colony-stimulating factor for neutropenia secondary to ticlopidine.

G Ruiz-Irastorza1, J J Alonso, J J Iglesias, C Aguirre.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7517606     DOI： 10.1159/000204302

Source DB:  PubMed          Journal:  Acta Haematol        ISSN： 0001-5792            Impact factor:   2.195


× No keyword cloud information.
  4 in total

1.  Hematologic dyscrasia associated with ticlopidine therapy: evidence for causality.

Authors:  F L Paradiso-Hardy; C M Angelo; K L Lanctôt; E A Cohen
Journal:  CMAJ       Date:  2000-11-28       Impact factor: 8.262

2.  Ticlopidine-induced severe neutropenia.

Authors:  H Gur; R Wartenfeld; D Tanne; F Solomon; Y Sidi
Journal:  Postgrad Med J       Date:  1998-02       Impact factor: 2.401

Review 3.  Ticlopidine. A review of its pharmacology, clinical efficacy and tolerability in the prevention of cerebral ischaemia and stroke.

Authors:  S Noble; K L Goa
Journal:  Drugs Aging       Date:  1996-03       Impact factor: 3.923

Review 4.  Adverse haematological effects of ticlopidine. Prevention, recognition and management.

Authors:  B B Love; J Biller; M Gent
Journal:  Drug Saf       Date:  1998-08       Impact factor: 5.606
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.